For over 160 years, Pfizer has stood for innovation in the pharmaceutical industry, including the production of drugs for the treatment of cancer, infections, arthritis and cardiovascular diseases. In Berlin, this global drug manufacturer performs intensive clinical research into new active pharmaceutical ingredients. Short distances between science, industry associations, political bodies and companies make Berlin the center of the healthcare sector in Germany. Berlin – the place to be for future industries.

Karsten Graudenz - Business Unit Director Pulmonary Vascular in Deutschland, Pfizer

be open, be curious, be berlin

"Even when I was a young doctor at the Münster University Hospital, I was very interested in the process of integrating medical knowledge into a business context. Ten years ago, for exactly this reason, I took up a position at Pfizer, at first in the medical-science field. Now I head up a business unit and coordinate marketing and sales for medications designed to treat pulmonary hypertension and cardiac insufficiency. What I really like about Pfizer is its dynamic corporate culture. Young colleagues take on responsibility very quickly and are given support and room to develop further. This dynamic can also be felt in our offices at Potsdamer Platz where things are open and transparent, colleagues are always accessible and you don’t have to go far to access them. By the way, the same also goes for our partners in research. In Berlin, we have many prominent universities and biotech companies right at our doorstep. For a pharmaceutical company like Pfizer, the city is the perfect place to be."

Martin Fensch, Company Spokesperson Pfizer:

"Berlin is Germany’s healthcare capital and has the potential to become Europe’s most important healthcare city, as well. This is a development that will shape the city as an industrial location, and Pfizer is eager to make an active contribution to this process."